Clevudine to be released in the Philippines

Published: 2009-09-22 06:57:00

Updated: 2009-09-22 06:57:00

Bukwang Pharm said on September 17 that its homegrown medicine clevudine (generic name) will be launched in the Philippines by HI-Eisai Pharmaceutical Inc. a subsidiary in the Philippines of Eisai Co., Ltd.

The Bureau of Food and Drugs (BFAD) in the Philippines approved on March 3 clevudine fo...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK